Price T Rowe Associates Inc Legend Biotech Corp Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Legend Biotech Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 10,949,120 shares of LEGN stock, worth $477 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
10,949,120
Previous 10,808,216
1.3%
Holding current value
$477 Million
Previous $650 Million
5.57%
% of portfolio
0.08%
Previous 0.09%
Shares
11 transactions
Others Institutions Holding LEGN
# of Institutions
213Shares Held
63.6MCall Options Held
1.09MPut Options Held
525K-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$260 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.38MShares$234 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.61MShares$114 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA2.39MShares$104 Million0.02% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.24MShares$97.5 Million0.67% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $7.29B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...